[
  {
    "ts": null,
    "headline": "The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue?",
    "summary": "The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=3bddd6015887b3650dad9252126ae2d49a8b27386617a4cfb223f32372385097",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758900603,
      "headline": "The Cooper Companies (COO) Up 3.6% Since Last Earnings Report: Can It Continue?",
      "id": 136897396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COO",
      "source": "Yahoo",
      "summary": "The Cooper Companies (COO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=3bddd6015887b3650dad9252126ae2d49a8b27386617a4cfb223f32372385097"
    }
  },
  {
    "ts": null,
    "headline": "3 Healthcare Stocks That Fall Short",
    "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 1.4%. This performance is a stark contrast from the S&P 500’s 15.7% gain.",
    "url": "https://finnhub.io/api/news?id=75d24bb48abbec1c637c8b0e04c49f8e2f808db85930756a4908ae0f796ab3ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758861567,
      "headline": "3 Healthcare Stocks That Fall Short",
      "id": 136890706,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "COO",
      "source": "Yahoo",
      "summary": "Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 1.4%. This performance is a stark contrast from the S&P 500’s 15.7% gain.",
      "url": "https://finnhub.io/api/news?id=75d24bb48abbec1c637c8b0e04c49f8e2f808db85930756a4908ae0f796ab3ba"
    }
  }
]